Source: International Congress 2018 – PG2 Thoracic ultrasound FULLY BOOKED



Rating:

Share or cite this content

Citations should be made in the following way:
C. Laursen (Odense, Denmark). Assessment of parenchymal abnormalities. International Congress 2018 – PG2 Thoracic ultrasound FULLY BOOKED

Member's Comments

No comment yet.

Related content which might interest you: PET-CT with 18F-FDG and 18F-FBEM-labeled leukocytes for metabolic activity and leukocyte recruitment monitoring in a mouse model of pulmonary fibrosis Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Lung 18F-FDG uptake correlates with lung function alteration in patients with IPF Source: International Congress 2014 – ILDs: pathogenesis and clinical features Year: 2014 Associations of interstitial lung abnormalities with physical function measures Source: International Congress 2018 – Clinical news in idiopathic interstitial pneumonias Year: 2018 Interstitial lung abnormalities and physical function Source: ERJ Open Res, 4 (3) 00057-2018; 10.1183/23120541.00057-2018 Year: 2018 From HRCT to morphology in diffuse parenchymal lung diseases(DPLDs) Source: International Congress 2014 – ILDs 1 Year: 2014 Evaluation and correlations of the extension of pulmonary cysts in lymphangioleiomyomatosis Source: Annual Congress 2013 –Diffuse parenchymal lung disease I Year: 2013 Comparison of physiological impairment in ILD patients with and without diagnostic IPF features Source: International Congress 2014 – ILDs 4 Year: 2014 Transient elastography detection of early liver fibrosis in idiopathic pulmonary fibrosis patients Source: International Congress 2014 – ILDs 2 Year: 2014 Assessment of disease severity using imaging scores in pulmonary sarcoidosis Source: Annual Congress 2012 - Diffuse parenchymal lung disease II Year: 2012 Idiopathic pulmonary fibrosis is associated with a preferential alteration of kCO rather than of DLCO Source: International Congress 2014 – ILDs 6 Year: 2014 Assessment of telomere length in the combined pulmonary fibrosis and emphysema syndrome Source: International Congress 2014 – ILDs: diagnostic and prognostic investigations Year: 2014 Prognostic influence of comorbidities in idiopathic pulmonary fibrosis (IPF) Source: International Congress 2014 – ILDs 2 Year: 2014 Discovery and validation of peripheral blood gene expression profiles predictive of poor outcome and disease progression in idiopathic pulmonary fibrosis Source: International Congress 2014 – Pathogenetic mechanisms in pulmonary fibrosis Year: 2014 6MWT performance by means of Spiropalm in patients affected by fibrotic idiopathic interstitial pneumonias: Preliminary observations Source: International Congress 2014 – ILDs 6 Year: 2014 Congenital lung abnormalities Source: Eur Respir Mon; 2010: 47: 263–276 Year: 2010 Diagnostic defects in interstitial lung diseases Source: Eur Respir J 2006; 28: Suppl. 50, 98s Year: 2006 Oxygen-enhanced MR (OE-MR): Correlation to CT Brody score in cystic fibrosis patients Source: International Congress 2016 – Cystic fibrosis: monitoring and management Year: 2016 Six-minute-walk test parameters in the prognostic evaluation of fibrotic lung diseases Source: International Congress 2014 – ILDs 4 Year: 2014 Disease progression in IPF assessed using pulmonary function tests and functional respiratory imaging (FRI) – A pilot study Source: International Congress 2014 – COPD and PAH related imaging Year: 2014 Longitudinal assessment of Lung Clearance Index as a marker of disease progression in a cohort of children with cystic fibrosis and normal spirometry Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020